Goodwin Procter advised Biotheus Inc. on the agreement with BioNTech. Biotheus Inc. announced an exclusive global license and collaboration agreement with BioNTech. BioNTech will be developing, manufacturing...
You must be a Standard 1 Year member to access this content.
KBP Biosciences was represented by Goodwin Procter LLP and Novo Nordisk was represented by Covington & Burling LLP in this transaction. Novo Nordisk A/S and KBP...
You must be a Standard 1 Year member to access this content.
Goodwin Procter served as legal counsel to C4T, and Han Kun Law Offices served as legal counsel to Betta. C4 Therapeutics, Inc. announced its exclusive licensing agreement...
You must be a Standard 1 Year member to access this content.
Goodwin advised OncoC4 on the deal. OncoC4 announced its agreement with BioNTech SE pursuant to which BioNTech receives an exclusive worldwide license to co-develop and commercialize OncoC4’s...
You must be a Standard 1 Year member to access this content.
Morgan Lewis represented Merck in the transaction. Merck closed its exclusive license and collaboration agreement with Kelun-Biotech, a holding subsidiary of Sichuan Kelun Pharmaceutical Co. Ltd., to...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Sichuan Kelun-Biotech Biopharmaceutical Co. on the deal. Sichuan Kelun-Biotech Biopharmaceutical Co. announced its exclusive license and collaboration agreement with Merck for ex-China development...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised HiFiBiO on the deal. HiFiBiO announced its oversubscribed $75 million Series D financing round. HiFiBiO is a multinational biotechnology company with unique expertise...
You must be a Standard 1 Year member to access this content.
